Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer.

PURPOSE To introduce an effective ambulatory technique in high-dose-rate interstitial brachytherapy (HDR-ISBT) for prostate cancer, we investigated the displacement distance using our novel calculation method. METHODS AND MATERIALS Sixty-four patients treated with HDR-ISBT as monotherapy were examined. Of these, 4, 17, and 43 patients were administered treatment doses of 38 Gy (3 days), 49 Gy (4 days), and 54 Gy (5 days), respectively. For dose administration, we used 776 flexible applicators with a removable template (ambulatory technique). Using CT images, we calculated the relative coordinates of the metal markers and applicators. From these coordinates, to analyze displacement during treatment, we measured the distance between the tip of the needle applicator and the center of gravity of the markers along the average applicator vector. RESULTS The median displacement distance for all applicators was 7 mm (range, -14 to 24), and that of each treatment schedule was 4, 6, and 9 mm for 38, 49, and 54 Gy, respectively. Of the 776 applicators, displacement of >10 mm was seen in 198 (26%) applicators and >15 mm in 57 (7%) applicators. Body height (p<0.0001) and anticoagulant usage (p<0.0001) were significant factors influencing displacement. CONCLUSIONS We investigated needle applicator displacement using our unique method. Additional cranial margins are necessary if there is no repositioning of the dwell position. CT scanning should be performed daily during treatment for checking the position of the applicator to detect and rectify the issue of displacement.

[1]  M. Beauduin,et al.  Feasibility study combining low dose rate (192)Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  G. Gustafson,et al.  Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. , 2001, International journal of radiation oncology, biology, physics.

[3]  P. Hoskin,et al.  High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  Bradley R Pieters,et al.  Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  New ambulatory implant technique of high-dose-rate interstitial brachytherapy for prostate cancer , 2006, Radiation Medicine.

[6]  Y. Yoshioka,et al.  High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. , 2000, International journal of radiation oncology, biology, physics.

[7]  R. Galalae,et al.  Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer , 1999, Strahlentherapie und Onkologie.

[8]  J. Pouliot,et al.  Measurement of craniocaudal catheter displacement between fractions in computed tomography–based high dose rate brachytherapy of prostate cancer , 2007, Journal of applied clinical medical physics.

[9]  I. Hsu,et al.  Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. , 2000, International journal of radiation oncology, biology, physics.

[10]  H. Yamazaki,et al.  New implant technique for separation of the seminal vesicle and rectal mucosa for high-dose-rate prostate brachytherapy. , 2007, Brachytherapy.

[11]  Glen Gejerman,et al.  Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. , 2004, International journal of radiation oncology, biology, physics.

[12]  R. Pötter,et al.  GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  D. Baltas,et al.  3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer , 2004, Strahlentherapie und Onkologie.

[14]  J. Blasko,et al.  Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. , 2003, International journal of radiation oncology, biology, physics.

[15]  S J Damore,et al.  Needle displacement during HDR brachytherapy in the treatment of prostate cancer. , 2000, International journal of radiation oncology, biology, physics.